Detection of grey matter loss in mild Alzheimer's disease with voxel based morphometry

Journal of Neurology Neurosurgery and Psychiatry

Volumn 73, Issue 6, 2002, Pages 657-664

  Frisoni, G B ^a   Testa, C ^a   Zorzan, A ^a   Sabattoli, F ^a   Beltramello, A ^b   Soininen, H ^c   Laakso, M P ^c  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALGORITHM; ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ARTICLE; AUTOANALYSIS; BRAIN ATROPHY; BRAIN MAPPING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENSITY; FEMALE; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MINI MENTAL STATE EXAMINATION; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETRIC TEST; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING;

EID: 0036904784     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.73.6.657     Document Type: Article

References (43)

1. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-94.
2. Bobinski M, de Leon MJ, Convit A, et al. MRI of entorhinol cortex in mild Alzheimer's disease. Lancet 1999;353:38-40.
3. Jack CR Jr, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-403.
4. Toga AW. Brain Warping. Toronto: Academic Press, 1999.
5. Csernansky JG, Wong L, Joshi S, et al. Eorly DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology 2000;55:1636-43.
6. Ashburner J, Friston KJ. Voxel-based morphometry - The methods. NeuroImage 2000;11:805-21.
7. Fox NC, Freeborough PA. Brain atrophy progression measured from registered serial MRI: Validation and application to Alzheimer's disease. J Magn Reson Imaging 1997;7:1069-75.
8. Frackowiak RSJ, Friston KJ, Frith CD, et al. Human Brain Function. Toronto: Academic Press, 1997.
9. Friston KJ, Frith CD, Liddle PF, et al. The relationship between global and local changes in PET scans. J Cereb Blood Flow Metab 1990;10:458-66.
10. Baron JC, Chételat G, Desgranges B, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. NeuroImage 2001;14:298-309.
11. Rombouts SA, Barkhof F, Witter MP, Scheltens P. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett 2000;285:231-3.
12. Ohnishi T, Matsuda H, Tabira T, et al. Changes in brain morphology in Alzheimer disease and normal ageing: Is Alzheimer disease an exaggerated aging process? AJNR Am J Neuroradiol 2001;22:1680-5.
13. Good CD, Johnsrude IS, Ashburner J, et al. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 2001;14:21-36.
14. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975;12:189-98.
15. McKhann G, Drachman D, Folstein MF, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
16. Frisoni GB, Beltramello A, Weiss C, et al. Linear measures of atrophy in mild Alzheimer's disease. AJNR Am J Neuroradiol 1996;17:913-23.
17. Hughes CP, Berg L, Danziger WL, et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-72.
18. Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2001;112:191-200.
19. Evans AC, Kamber M, Collins DL, et al. An MRI-based probabilistic atlas of neuroanatomy. In: Shorvon S, Fish D, Andermann F, et al, eds. Magnetic Resonance Scanning and Epilepsy. New York: Plenum Press 1994:263-74.
20. Ashburner J, Neelin P, Collins DL, et al. Incorporating prior knowledge into image registration. NeuroImage 1997;6:344-52.
21. Mai JK, Assheuer J, Paxinos G. Atlas of the Human Brain. New York: Academic Press, 1997.
22. Esiri MM, Pearson RC, Steele JE, et al. A quantitative study of the neurofibrillary tangles and the choline acetyltransferase activity in the cerebral cortex and the amygdala in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1990;53:161-5.
23. Convit A, de Asis J, de Leon MJ, et al. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease. Neurobiol Aging 2000;21:19-26.
24. Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease. Ann Neurol 1997;42:85-94.
25. Vogt BA, Van Hoesen GW, Vogt LJ. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease. Acta Neuropathol (Berl) 1990;80:581-9.
26. Mesulam MM, Nobre AC, Kim YH, et al. Heterogeneity of cingulate contributions to spatial attention. NeuroImage 2001;13:1065-72.
27. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med 2001;15:85-92.
28. Killiany RJ, Gomez-Isla T, Moss M, et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000;47:430-9.
29. Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563-71.
30. Braak H, Braak E. Alzheimer's disease: Striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol 1990;49:215-24.
31. Barber R, McKeith I, Ballard C, et al. Volumetric MRI study of the caudate nucleus in patients with dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. J Neurol Neurosurg Psychiatry 2002;72:406-7.
32. Bartzokis G, Tishler TA. MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease. Cell Mol Biol 2000;46:821-33.
33. Imran MB, Kawashima R, Awata S, et al. Tc-99m HMPAO SPECT in the evaluation of Alzheimer's disease: Correlation between neuropsychiatric evaluation and CBF images. J Neurol Neurosurg Psychiatry 1999;66:228-32.
34. Smith CD, Malcein M, Meurer K, et al. MRI temporal lobe volume measures and neuropsychologic function in Alzheimer's disease. J Neuroimaging 1999;9:2-9.
35. Grace J, Nadler JD, White DA, et al. Folstein vs modified Mini-Mental State Examination in geriatric stroke. Stability, validity, and screening utility. Arch Neurol 1995;52:477-84.
36. Meguro K, LeMestric C, Landeau B, et al. Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: A PET/MRI correlative study. J Neurol Neurosurg Psychiatry 2001;71:315-21.
37. Van Laere KJ, Dierckx RA. Brain perfusion SPECT: Age- and sex-related effects correlated with voxel-based morphometric findings in healthy adults. Radiology 2001;221:810-17.
38. Friston KJ, Penny W, Phillips C, et al. Classical and Bayesian inference in neuroimaging: Theory. NeuroImage 2002;16:465-83.
39. Thieben MJ, Duggins AJ, Good CD, et al. The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002;125:1815-28.
40. Kaufmann C, Schuld A Pollmacher T, et al. Reduced cortical gray matter in narcolepsy: Preliminary findings with voxel-based morphometry. Neurology 2002;58:1852-5.
41. Kassubek J, Juengling FD Hellwig B, et al. Thalamic gray matter changes in unilateral Parkinsonian resting tremor: A voxel-based morphometric analysis of 3-dimensional magnetic resonance imaging. Neurosci Lett 2002;323:29-32.
42. Franklin TR, Acton PD, Maldjian JA, et al. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry 2002;51:134-42.
43. Rosen HJ, Kramer JH, Gorno-Tempini ML, et al. Patterns of cerebral atrophy in primary progressive aphasia. Am J Geriatr Psychiatry 2002;10:89-97.